{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Angiogenesis inhibitors", "Lycorine", "Molecular docking simulation", "Platelet-derived growth factor alpha", "Receptor"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35948939", "DateCompleted": {"Year": "2022", "Month": "08", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "08", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "10"}], "Language": ["eng"], "ELocationID": ["873", "10.1186/s12885-022-09929-y"], "Journal": {"ISSN": "1471-2407", "JournalIssue": {"Volume": "22", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Aug", "Day": "10"}}, "Title": "BMC cancer", "ISOAbbreviation": "BMC Cancer"}, "ArticleTitle": "Lycorine inhibits angiogenesis by docking to PDGFR\u03b1.", "Pagination": {"StartPage": "873", "MedlinePgn": "873"}, "Abstract": {"AbstractText": ["Lycorine (Lyc) is a natural alkaloid derived from medicinal plants of the Amaryllidaceae family. Lyc has been reported to inhibit the recurrence and metastasis of different kinds of tumors. However, Lyc's effect on angiogenesis and its specific mechanism are still not clear. This study was designed to test the antiangiogenesis effect of Lyc and to explore the possible mechanisms. We performed cell experiments to confirm Lyc's inhibitory effect on angiogenesis and employed sunitinib as a positive control. Moreover, the synergistic effect of Lyc and sunitinib was also explored. Next, we conducted bioinformatics analyses to predict the potential targets of Lyc and verified them by western blotting and immunofluorescence. Molecular docking, kinase activity assays, Biacore assays and cellular thermal shift assays (CETSAs) were applied to elucidate the mechanism by which Lyc inhibited target activity. Lyc inhibited angiogenesis in human umbilical vein endothelial cells (HUVECs). Employing bioinformatics, we found that Lyc's target was PDGFR\u03b1 and that Lyc attenuated PDGFR\u03b1 phosphorylation. We also found that Lyc inhibited PDGFR\u03b1 activation by docking to it to restrain its activity. Additionally, Lyc significantly inhibited PDGF-AA-induced angiogenesis. This study provides new insights into the molecular functions of Lyc and indicates its potential as a therapeutic agent for tumor angiogenesis."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110000, Liaoning Province, China."}], "LastName": "Lv", "ForeName": "Fei", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology III, People's Hospital of Liaoning Provinve, Shenyang, , Liaoning, China."}], "LastName": "Li", "ForeName": "XiaoQi", "Initials": "X"}, {"Identifier": ["0000-0002-6941-707X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110000, Liaoning Province, China. wang_ying@sj-hospital.org."}], "LastName": "Wang", "ForeName": "Ying", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800", "ISSNLinking": "1471-2407"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amaryllidaceae Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Angiogenesis Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenanthridines"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Receptor, Platelet-Derived Growth Factor alpha"}, {"RegistryNumber": "I9Q105R5BU", "NameOfSubstance": "lycorine"}, {"RegistryNumber": "V99T50803M", "NameOfSubstance": "Sunitinib"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Amaryllidaceae Alkaloids"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Angiogenesis Inhibitors"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Human Umbilical Vein Endothelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neovascularization, Pathologic"}, {"QualifierName": [], "DescriptorName": "Phenanthridines"}, {"QualifierName": [], "DescriptorName": "Receptor, Platelet-Derived Growth Factor alpha"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Sunitinib"}], "CoiStatement": "The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370. doi: 10.1016/S0092-8674(00)81683-9.", "ArticleIdList": ["10.1016/S0092-8674(00)81683-9", "10647931"]}, {"Citation": "Melegh Z, Oltean S. Targeting angiogenesis in prostate cancer. Int J Mol Sci.\u00a02019;20(11).", "ArticleIdList": ["PMC6600172", "31151317"]}, {"Citation": "Zhang Z, Ji S, Zhang B, et al. Role of angiogenesis in pancreatic cancer biology and therapy. Biomed Pharmacother. 2018;108:1135\u20131140. doi: 10.1016/j.biopha.2018.09.136.", "ArticleIdList": ["10.1016/j.biopha.2018.09.136", "30372814"]}, {"Citation": "Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci. 2020;77(9):1745\u20131770. doi: 10.1007/s00018-019-03351-7.", "ArticleIdList": ["10.1007/s00018-019-03351-7", "PMC7190605", "31690961"]}, {"Citation": "Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382(20):1894\u20131905. doi: 10.1056/NEJMoa1915745.", "ArticleIdList": ["10.1056/NEJMoa1915745", "32402160"]}, {"Citation": "Liu X, Qin S, Wang Z, et al. Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study. J Hematol Oncol. 2017;10(1):153. doi: 10.1186/s13045-017-0521-0.", "ArticleIdList": ["10.1186/s13045-017-0521-0", "PMC5584332", "28870253"]}, {"Citation": "Liang XJ, Shen J. Adverse events risk associated with angiogenesis inhibitors addition to therapy in ovarian cancer: a meta-analysis of randomized controlled trials. Eur Rev Med Pharmacol Sci. 2016;20(12):2701\u20132709.", "ArticleIdList": ["27383326"]}, {"Citation": "Kim A, Ha J, Kim J, et al. Natural products for pancreatic cancer treatment: from traditional medicine to modern drug discovery. Nutrients.\u00a02021;13(11).", "ArticleIdList": ["PMC8625071", "34836055"]}, {"Citation": "Yang Y, Liu Q, Shi X, et al. Advances in plant-derived natural products for antitumor immunotherapy. Arch Pharm Res. 2021;44(11):987\u20131011. doi: 10.1007/s12272-021-01355-1.", "ArticleIdList": ["10.1007/s12272-021-01355-1", "34751930"]}, {"Citation": "Li R, Song X, Guo Y, et al. Natural products: a promising therapeutics for targeting tumor angiogenesis. Front Oncol. 2021;11:772915. doi: 10.3389/fonc.2021.772915.", "ArticleIdList": ["10.3389/fonc.2021.772915", "PMC8570131", "34746014"]}, {"Citation": "Kaya GI, Cicek D, Sarikaya B, et al. HPLC - DAD analysis of lycorine in Amaryllidaceae species. Nat Prod Commun. 2010;5(6):873\u2013876.", "ArticleIdList": ["20614813"]}, {"Citation": "Wu J, Fu Y, Wu YX, et al. Lycorine ameliorates isoproterenol-induced cardiac dysfunction mainly via inhibiting inflammation, fibrosis, oxidative stress and apoptosis. Bioengineered. 2021;12(1):5583\u20135594. doi: 10.1080/21655979.2021.1967019.", "ArticleIdList": ["10.1080/21655979.2021.1967019", "PMC8806515", "34515620"]}, {"Citation": "Lv X, Zhang M, Yu S, et al. Antiviral and virucidal activities of lycorine on duck tembusu virus in vitro by blocking viral internalization and entry. Poult Sci. 2021;100(10):101404. doi: 10.1016/j.psj.2021.101404.", "ArticleIdList": ["10.1016/j.psj.2021.101404", "PMC8414183", "34478911"]}, {"Citation": "Shen JW, Ruan Y, Ren W, et al. Lycorine: a potential broad-spectrum agent against crop pathogenic fungi. J Microbiol Biotechnol. 2014;24(3):354\u2013358. doi: 10.4014/jmb.1310.10063.", "ArticleIdList": ["10.4014/jmb.1310.10063", "24346469"]}, {"Citation": "Roy M, Liang L, Xiao X, et al. Lycorine: a prospective natural lead for anticancer drug discovery. Biomed Pharmacother. 2018;107:615\u2013624. doi: 10.1016/j.biopha.2018.07.147.", "ArticleIdList": ["10.1016/j.biopha.2018.07.147", "PMC7127747", "30114645"]}, {"Citation": "Shawky E, Takla SS, Hammoda HM, et al. Evaluation of the influence of green extraction solvents on the cytotoxic activities of crinum (Amaryllidaeae) alkaloid extracts using in-vitro-in-silico approach. J Ethnopharmacol. 2018;227:139\u2013149. doi: 10.1016/j.jep.2018.08.040.", "ArticleIdList": ["10.1016/j.jep.2018.08.040", "30179713"]}, {"Citation": "Shen J, Zhang T, Cheng Z, et al. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression. J Exp Clin Cancer Res. 2018;37(1):157. doi: 10.1186/s13046-018-0785-4.", "ArticleIdList": ["10.1186/s13046-018-0785-4", "PMC6050662", "30016965"]}, {"Citation": "Yin S, Yang S, Luo Y, et al. Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma. Biochem Pharmacol. 2021;193:114806. doi: 10.1016/j.bcp.2021.114806.", "ArticleIdList": ["10.1016/j.bcp.2021.114806", "34673013"]}, {"Citation": "Zhao Z, Xiang S, Qi J, et al. Correction of the tumor suppressor Salvador homolog-1 deficiency in tumors by lycorine as a new strategy in lung cancer therapy. Cell Death Dis. 2020;11(5):387. doi: 10.1038/s41419-020-2591-0.", "ArticleIdList": ["10.1038/s41419-020-2591-0", "PMC7242319", "32439835"]}, {"Citation": "Yuan XH, Zhang P, Yu TT, et al. Lycorine inhibits tumor growth of human osteosarcoma cells by blocking Wnt/beta-catenin, ERK1/2/MAPK and PI3K/AKT signaling pathway. Am J Transl Res. 2020;12(9):5381\u20135398.", "ArticleIdList": ["PMC7540099", "33042426"]}, {"Citation": "Ning L, Wan S, Jie Z. Lycorine Induces Apoptosis and G1 Phase Arrest Through ROS/p38 MAPK Signaling Pathway in Human Osteosarcoma Cells In Vitro and In Vivo. Spine (Phila Pa 1976) 2020;45(3):E126\u2013E139. doi: 10.1097/BRS.0000000000003217.", "ArticleIdList": ["10.1097/BRS.0000000000003217", "31464976"]}, {"Citation": "Yu H, Qiu Y, Pang X, et al. Lycorine promotes autophagy and apoptosis via TCRP1/Akt/mTOR axis inactivation in human hepatocellular carcinoma. Mol Cancer Ther. 2017;16(12):2711\u20132723. doi: 10.1158/1535-7163.MCT-17-0498.", "ArticleIdList": ["10.1158/1535-7163.MCT-17-0498", "28974556"]}, {"Citation": "Liu R, Cao Z, Tu J, et al. Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry. Pigment Cell Melanoma Res. 2012;25(5):630\u2013638. doi: 10.1111/j.1755-148X.2012.01036.x.", "ArticleIdList": ["10.1111/j.1755-148X.2012.01036.x", "22781316"]}, {"Citation": "Cao Z, Yu D, Fu S, et al. Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicol Lett. 2013;218(2):174\u2013185. doi: 10.1016/j.toxlet.2013.01.018.", "ArticleIdList": ["10.1016/j.toxlet.2013.01.018", "23376478"]}, {"Citation": "Hopkins A. Network pharmacology. Nat Biotechnol. 2007;25(10):1110\u20131111. doi: 10.1038/nbt1007-1110.", "ArticleIdList": ["10.1038/nbt1007-1110", "17921993"]}, {"Citation": "Gao L, Feng Y, Ge C, et al. Identification of molecular anti-metastasis mechanisms of lycorine in colorectal cancer by RNA-seq analysis. Phytomedicine. 2021;85:153530. doi: 10.1016/j.phymed.2021.153530.", "ArticleIdList": ["10.1016/j.phymed.2021.153530", "33761445"]}, {"Citation": "Liu X, Ouyang S, Yu B, et al. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res. 2010;38(Web Server issue):W609\u2013W614. doi: 10.1093/nar/gkq300.", "ArticleIdList": ["10.1093/nar/gkq300", "PMC2896160", "20430828"]}, {"Citation": "Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25\u201329. doi: 10.1038/75556.", "ArticleIdList": ["10.1038/75556", "PMC3037419", "10802651"]}, {"Citation": "Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330. doi: 10.1093/nar/28.1.27.", "ArticleIdList": ["10.1093/nar/28.1.27", "PMC102409", "10592173"]}, {"Citation": "Ogata H, Goto S, Sato K, et al. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999;27(1):29\u201334. doi: 10.1093/nar/27.1.29.", "ArticleIdList": ["10.1093/nar/27.1.29", "PMC148090", "9847135"]}, {"Citation": "Zhang B, Kirov S, Snoddy J. WebGestalt:an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005;33(Web Server issue):W741\u2013W748. doi: 10.1093/nar/gki475.", "ArticleIdList": ["10.1093/nar/gki475", "PMC1160236", "15980575"]}, {"Citation": "Saito R, Smoot ME, Ono K, et al. A travel guide to Cytoscape plugins. Nat Methods. 2012;9(11):1069\u20131076. doi: 10.1038/nmeth.2212.", "ArticleIdList": ["10.1038/nmeth.2212", "PMC3649846", "23132118"]}, {"Citation": "Lv F, Deng M, Bai J, et al. Piperlongumine inhibits head and neck squamous cell carcinoma proliferation by docking to Akt. Phytother Res. 2020;34(12):3345\u20133358. doi: 10.1002/ptr.6788.", "ArticleIdList": ["10.1002/ptr.6788", "32798277"]}, {"Citation": "Rose PW, Prlic A, Altunkaya A, et al. The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic Acids Res. 2017;45(D1):D271\u2013D281.", "ArticleIdList": ["PMC5210513", "27794042"]}, {"Citation": "Friesner R A, Banks J L, Murphy R B, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47(7):1739\u20131749. doi: 10.1021/jm0306430.", "ArticleIdList": ["10.1021/jm0306430", "15027865"]}, {"Citation": "Halgren T A, Murphy R B, Friesner R A, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004;47(7):1750\u20131759. doi: 10.1021/jm030644s.", "ArticleIdList": ["10.1021/jm030644s", "15027866"]}, {"Citation": "Leonard P, Hearty S, Ma H, et al. Measuring protein-protein interactions using Biacore. Methods Mol Biol. 2017;1485:339\u2013354. doi: 10.1007/978-1-4939-6412-3_17.", "ArticleIdList": ["10.1007/978-1-4939-6412-3_17", "27730561"]}, {"Citation": "Leonard P, Hearty S, O'Kennedy R. Measuring protein-protein interactions using Biacore. Methods Mol Biol. 2011;681:403\u2013418. doi: 10.1007/978-1-60761-913-0_22.", "ArticleIdList": ["10.1007/978-1-60761-913-0_22", "20978978"]}, {"Citation": "de Bouard S, Herlin P, Christensen JG, et al. Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma. Neuro Oncol. 2007;9(4):412\u2013423. doi: 10.1215/15228517-2007-024.", "ArticleIdList": ["10.1215/15228517-2007-024", "PMC1994098", "17622648"]}, {"Citation": "Gu J, Zhang Y, Han Z, et al. Targeting the ERbeta/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC. Cell Death Dis. 2020;11(5):367. doi: 10.1038/s41419-020-2486-0.", "ArticleIdList": ["10.1038/s41419-020-2486-0", "PMC7224303", "32409702"]}, {"Citation": "Zhang HP, Takayama K, Su B, et al. Effect of sunitinib combined with ionizing radiation on endothelial cells. J Radiat Res. 2011;52(1):1\u20138. doi: 10.1269/jrr.10013.", "ArticleIdList": ["10.1269/jrr.10013", "21187670"]}, {"Citation": "Zhang P, Li S, Chen Z, et al. LncRNA SNHG8 promotes proliferation and invasion of gastric cancer cells by targeting the miR-491/PDGFRA axis. Hum Cell. 2020;33(1):123\u2013130. doi: 10.1007/s13577-019-00290-0.", "ArticleIdList": ["10.1007/s13577-019-00290-0", "31620977"]}, {"Citation": "Nguyen CT, Tanaka K, Cao Y, et al. Computational analysis of the ligand binding site of the extracellular ATP receptor, DORN1. PLoS ONE. 2016;11(9):e161894.", "ArticleIdList": ["PMC5008829", "27583834"]}, {"Citation": "Shi S, Li C, Zhang Y, et al. Lycorine hydrochloride inhibits melanoma cell proliferation, migration and invasion via down-regulating p21(Cip1/WAF1) Am J Cancer Res. 2021;11(4):1391\u20131409.", "ArticleIdList": ["PMC8085853", "33948364"]}, {"Citation": "Li C, Deng C, Pan G, et al. Lycorine hydrochloride inhibits cell proliferation and induces apoptosis through promoting FBXW7-MCL1 axis in gastric cancer. J Exp Clin Cancer Res. 2020;39(1):230. doi: 10.1186/s13046-020-01743-3.", "ArticleIdList": ["10.1186/s13046-020-01743-3", "PMC7602321", "33126914"]}, {"Citation": "Huang CY, Yu LC. Pathophysiological mechanisms of death resistance in colorectal carcinoma. World J Gastroenterol. 2015;21(41):11777\u201311792. doi: 10.3748/wjg.v21.i41.11777.", "ArticleIdList": ["10.3748/wjg.v21.i41.11777", "PMC4631976", "26557002"]}, {"Citation": "Mongiat M, Buraschi S, Andreuzzi E, et al. Extracellular matrix: the gatekeeper of tumor angiogenesis. Biochem Soc Trans. 2019;47(5):1543\u20131555. doi: 10.1042/BST20190653.", "ArticleIdList": ["10.1042/BST20190653", "31652436"]}, {"Citation": "Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298\u2013307. doi: 10.1038/nature10144.", "ArticleIdList": ["10.1038/nature10144", "PMC4049445", "21593862"]}, {"Citation": "Shanmugam MK, Warrier S, Kumar AP, et al. Potential role of natural compounds as anti-angiogenic agents in cancer. Curr Vasc Pharmacol. 2017;15(6):503\u2013519. doi: 10.2174/1570161115666170713094319.", "ArticleIdList": ["10.2174/1570161115666170713094319", "28707601"]}, {"Citation": "Ribatti D. The chick embryo chorioallantoic membrane as a model for tumor biology. Exp Cell Res. 2014;328(2):314\u2013324. doi: 10.1016/j.yexcr.2014.06.010.", "ArticleIdList": ["10.1016/j.yexcr.2014.06.010", "24972385"]}, {"Citation": "Ribatti D, Tamma R. The chick embryo chorioallantoic membrane as an in vivo experimental model to study multiple myeloma. Enzymes. 2019;46:23\u201335. doi: 10.1016/bs.enz.2019.08.006.", "ArticleIdList": ["10.1016/bs.enz.2019.08.006", "31727275"]}, {"Citation": "Pluchino N, Poppi G, Yart L, et al. Effect of local aromatase inhibition in endometriosis using a new chick embryo chorioallantoic membrane model. J Cell Mol Med. 2019;23(8):5808\u20135812. doi: 10.1111/jcmm.14372.", "ArticleIdList": ["10.1111/jcmm.14372", "PMC6653393", "31199588"]}, {"Citation": "Sil S, Periyasamy P, Thangaraj A, et al. PDGF/PDGFR axis in the neural systems. Mol Aspects Med. 2018;62:63\u201374. doi: 10.1016/j.mam.2018.01.006.", "ArticleIdList": ["10.1016/j.mam.2018.01.006", "PMC6003857", "29409855"]}, {"Citation": "Al-Share B, Alloghbi A, Al HM, et al. Gastrointestinal stromal tumor: a review of current and emerging therapies. Cancer Metastasis Rev. 2021;40(2):625\u2013641. doi: 10.1007/s10555-021-09961-7.", "ArticleIdList": ["10.1007/s10555-021-09961-7", "33876372"]}, {"Citation": "Liang L, Yan XE, Yin Y, et al. Structural and biochemical studies of the PDGFRA kinase domain. Biochem Biophys Res Commun. 2016;477(4):667\u2013672. doi: 10.1016/j.bbrc.2016.06.117.", "ArticleIdList": ["10.1016/j.bbrc.2016.06.117", "27349873"]}, {"Citation": "Franchini A, Malagoli D, Ottaviani E. Cytokines and invertebrates: TGF-beta and PDGF. Curr Pharm Des. 2006;12(24):3025\u20133031. doi: 10.2174/138161206777947524.", "ArticleIdList": ["10.2174/138161206777947524", "16918431"]}, {"Citation": "Gianni-Barrera R, Bartolomeo M, Vollmar B, et al. Split for the cure: VEGF, PDGF-BB and intussusception in therapeutic angiogenesis. Biochem Soc Trans. 2014;42(6):1637\u20131642. doi: 10.1042/BST20140234.", "ArticleIdList": ["10.1042/BST20140234", "25399582"]}, {"Citation": "Dong D, Xu Z, Zhong W, et al. Parallelization of molecular docking: a review. Curr Top Med Chem. 2018;18(12):1015\u20131028. doi: 10.2174/1568026618666180821145215.", "ArticleIdList": ["10.2174/1568026618666180821145215", "30129415"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "4"}, {"Year": "2022", "Month": "7", "Day": "22"}, {"Year": "2022", "Month": "8", "Day": "10", "Hour": "23", "Minute": "38"}, {"Year": "2022", "Month": "8", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["35948939", "PMC9364594", "10.1186/s12885-022-09929-y", "10.1186/s12885-022-09929-y"]}}], "PubmedBookArticle": []}